The past week has been a whirlwind of economic predictions and policy speculations, largely centered around President-elect Donald Trump’s potential second term. read more ​ ​The past week has been a whirlwind of economic predictions and policy speculations, largely centered around President-elect Donald Trump’s potential second term. read moreÂ
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga’s Deal Dispatch has the latest M&A updates. read more ​ ​Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga’s Deal Dispatch has the latest M&A updates. read moreÂ
Chinese President Xi Jinping has expressed China’s willingness to collaborate with the U.S. government, regardless of the administration in power. This statement comes amid the ongoing U.S.-China tensions and the impending return of Donald Trump to the White House. read more ​ ​Chinese President Xi Jinping has expressed China’s willingness to collaborate with the U.S.
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.